Skip to main content

Table 5 Estimated average treatment effects on the treated according to coronary intervention of the two groups (PPCI primary percutaneous coronary intervention, PIs: pharmacoinvasive strategy) adjusted for covariates

From: Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

Outcome variable Sample Treated Control Difference S.E P value
30-day cardiovascular death or symptomatic heart failure ATT 0.212 0.295 − 0.083 0.132 0.527
Successful reperfusion after PCI ATT 0.824 0.922 − 0.099 0.065 0.127
  1. Covariates include: age, sex, initial TIMI, total ischemia-to-reperfusion time, time to first contact, hypertension, diabetes mellitus, chronic kidney disease, cardiac arrest, and location)
  2. ATT average treatment effects on the treated; S.E. definer, PCI percutaneous coronary intervention